Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical benefits of Paclitaxel plus Carboplatin compared with Paclitaxel
plus Cisplatin in Stage IVb, Persistent, or Recurrent Cervical Cancer